The following data is part of a premarket notification filed by Primus, Inc. with the FDA for Primus Model Clc 330.
Device ID | K891235 |
510k Number | K891235 |
Device Name: | PRIMUS MODEL CLC 330 |
Classification | Assay, Glycosylated Hemoglobin |
Applicant | PRIMUS, INC. 4747 TROOST Kansas City, MO 64110 |
Contact | Janet Svoboda |
Correspondent | Janet Svoboda PRIMUS, INC. 4747 TROOST Kansas City, MO 64110 |
Product Code | LCP |
CFR Regulation Number | 864.7470 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 1989-03-07 |
Decision Date | 1989-06-16 |
Device Identifier | submissionNumber | Supplement |
---|---|---|
05391516748636 | K891235 | 000 |
05391516744164 | K891235 | 000 |
05391516744171 | K891235 | 000 |
05391516744218 | K891235 | 000 |
05391516744270 | K891235 | 000 |
05391516744287 | K891235 | 000 |
05391516744294 | K891235 | 000 |
05391516744317 | K891235 | 000 |
05391516744546 | K891235 | 000 |
05391516744553 | K891235 | 000 |
05391516748155 | K891235 | 000 |
05391516748162 | K891235 | 000 |
05391516748605 | K891235 | 000 |
05391516748612 | K891235 | 000 |
05391516748629 | K891235 | 000 |
05391516744126 | K891235 | 000 |